The fast-growing new business partner of Rainbow Coral Corp (OTCBB:RBCC.OB – News) subsidiary Rainbow BioSciences, Nano3D BioSciences (n3D), has been hitting the road hard to spread awareness in the research community about its latest biotech breakthrough: the Bio-Assembler.

N3D introduced its cell-levitation technology to dozens of potential clients at M.D. Anderson Cancer Center in Houston last week at the 28th Southern Biomedical Engineering Conference before making a poster presentation at the NSF 2012 SBIR/STTR Phase II Grantees Conference in Baltimore. The biotech innovators then wrapped the week with an appearance at an important trade show: The Biomedical research Equipment and Supplies Exhibit at the National Cancer Institute at Frederick.

The promotional and networking events are a crucial piece of n3D and RBCC’s strategy to build strong interest in the Bio-Assembler among researchers across a broad spectrum of scientific and research disciplines. The system’s revolutionary functionality allows it to produce accurate, 3D representations of in vivo tissues in roughly the same time needed to produce 2D cell cultures. It’s a great leap forward poised to dramatically shorten research timelines around the globe.

N3D has more conferences and presentations scheduled through the remainder of the year, including a trip to Japan.

Rainbow BioSciences acquired an equity interest in n3D earlier this year. RBCC believes that this acquisition has the company well-positioned to participate in the potentially impressive upside in store for n3D.